LEMAITRE VASCULAR, INC. Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
LEMAITRE VASCULAR, INC. (LMAT) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price of $39.34 per share for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice · last filed 2026-02-26
- LEMAITRE VASCULAR, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2025 was $39.34, a 8.79% increase from fiscal 2024.
- LEMAITRE VASCULAR, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2024 was $36.16, a 21.67% increase from fiscal 2023.
- LEMAITRE VASCULAR, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2023 was $29.72, a 15.19% increase from fiscal 2022.
- LEMAITRE VASCULAR, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2022 was $25.80, a 0.00% change from fiscal 2021.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 12 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 12 month as first filed |
|---|---|---|
| 2025-12-31 | $39.34 10-K · filed 2026-02-26 | |
| 2024-12-31 | $36.16 10-K · filed 2026-02-26 | |
| 2023-12-31 | $29.72 10-K · filed 2026-02-26 | |
| 2022-12-31 | $25.80 10-K · filed 2025-02-28 | |
| 2021-12-31 | $25.80 10-K · filed 2024-02-29 | $20.95 10-K · filed 2022-02-28 |
| 2020-12-31 | $20.95 10-K · filed 2024-02-29 | $17.99 10-K · filed 2021-03-12 |
| 2019-12-31 | $9.53 10-K · filed 2022-02-28 | |
| 2018-12-31 | $9.79 10-K · filed 2019-03-11 | |
| 2017-12-31 | $8.65 10-K · filed 2018-03-09 | |
| 2016-12-31 | $6.17 10-K · filed 2017-03-09 | |
| 2015-12-31 | $5.33 10-K · filed 2016-03-10 | |
| 2014-12-31 | $3.33 10-K · filed 2015-03-18 | |
| 2013-12-31 | $3.96 10-K · filed 2014-03-21 | |
| 2012-12-31 | $3.17 10-K · filed 2013-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |